These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 20938914)

  • 1. Consumption of serum lipid-reducing drugs in Serbia compared with Scandinavian countries: a population-based study, 2004-2008.
    Sabo A; Tomić Z; Stilinović N; Milijašević B; Mikov M; Vukmirović S; Horvat O
    Pharmacoepidemiol Drug Saf; 2011 Jan; 20(1):45-9. PubMed ID: 20938914
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipid-lowering drugs.
    Med Lett Drugs Ther; 2016 Oct; 58(1506):133-140. PubMed ID: 27755510
    [No Abstract]   [Full Text] [Related]  

  • 3. Assessment of lipid-lowering treatment in France--the CEPHEUS study.
    Ferrières J; Gousse ET; Fabry C; Hermans MP;
    Arch Cardiovasc Dis; 2008 Sep; 101(9):557-63. PubMed ID: 19041840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Statins in coronary artery bypass grafting surgery: lipid lowering and beyond.
    Margaritis M; Antoniades C
    Expert Rev Cardiovasc Ther; 2012 Jan; 10(1):5-8. PubMed ID: 22149521
    [No Abstract]   [Full Text] [Related]  

  • 5. [Metabolically designed treatments: from biochemistry to the vessel lining].
    Moulin P
    Rev Med Interne; 2007 Jun; 28 Suppl 1():S12-3. PubMed ID: 17466416
    [No Abstract]   [Full Text] [Related]  

  • 6. Use of intensive lipid-lowering therapy in patients hospitalized with acute coronary syndrome: an analysis of 65,396 hospitalizations from 344 hospitals participating in Get With The Guidelines (GWTG).
    Javed U; Deedwania PC; Bhatt DL; Cannon CP; Dai D; Hernandez AF; Peterson ED; Fonarow GC
    Am Heart J; 2010 Dec; 160(6):1130-6, 1136.e1-3. PubMed ID: 21146668
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recommendations of the second Indo-U.S. health summit on prevention and control of cardiovascular disease among Asian Indians.
    Enas EA; Singh V; Munjal YP; Gupta R; Patel KC; Bhandari S; Agarwal AK; Joshi SR; Anoop M; Prabhakaran D; Shah B; Reddy S; Sharma B; Trehan N; Yavagal ST; Kasliwal RR;
    Indian Heart J; 2009; 61(3):265-74. PubMed ID: 20503833
    [No Abstract]   [Full Text] [Related]  

  • 8. [Preadmission use of statins as treatment for strokes].
    González-Hernández A; López-Fernández JC; Fabre-Pi O; Cubero A
    Rev Neurol; 2007 Dec 1-15; 45(11):702-3. PubMed ID: 18050107
    [No Abstract]   [Full Text] [Related]  

  • 9. [Comparison of utilization of cardiovascular drugs in the Czech Republic and in Wales].
    Górecká K; Vlcek J; Walker R
    Vnitr Lek; 2003 Aug; 49(8):592-7. PubMed ID: 14518081
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical trials. Lipid-lowering therapy and postoperative complications.
    DeSilvey DL
    Am J Geriatr Cardiol; 2004; 13(5):278. PubMed ID: 15365293
    [No Abstract]   [Full Text] [Related]  

  • 11. [Current evidence about lipid-lowering therapy and coronary plaque].
    Otake H; Hirata K
    Nihon Rinsho; 2011 Sep; 69 Suppl 7():95-102. PubMed ID: 22518972
    [No Abstract]   [Full Text] [Related]  

  • 12. [Should the treatment of diabetic dyslipidemia be modified after the Action to Control Cardiovascular Risk in Diabetes Lipid study?].
    Pérez A
    Endocrinol Nutr; 2010 Dec; 57(10):457-9. PubMed ID: 20688585
    [No Abstract]   [Full Text] [Related]  

  • 13. Insights from recent meta-analysis: role of high-density lipoprotein cholesterol in reducing cardiovascular events and rates of atherosclerotic disease progression.
    Negi S; Ballantyne CM
    J Clin Lipidol; 2010; 4(5):365-70. PubMed ID: 21122680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. One great leap for lipid lowering drugs.
    Cardiovasc J S Afr; 2002; 13(5):265-6. PubMed ID: 12557874
    [No Abstract]   [Full Text] [Related]  

  • 15. Strategies for management and treatment of dyslipidemia in HIV/AIDS.
    Sax PE
    AIDS Care; 2006 Feb; 18(2):149-57. PubMed ID: 16338773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiovascular disease and statin drugs.
    Campbell AW
    Altern Ther Health Med; 2014; 20(5):8-9. PubMed ID: 25141364
    [No Abstract]   [Full Text] [Related]  

  • 17. The impact of pharmaceuticals on the decline of cardiovascular mortality in Germany.
    Häussler B; Schiffhorst G; Gothe H; Hempel E
    Pharmacoepidemiol Drug Saf; 2007 Oct; 16(10):1167-76. PubMed ID: 17551995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness of lipid lowering drugs in general practice: article illustrates major problem.
    Wang TW; Livingstone CA; Ferns GA
    BMJ; 2003 Jul; 327(7405):50-1; author reply 51. PubMed ID: 12842961
    [No Abstract]   [Full Text] [Related]  

  • 19. The association of lipid-modifying medications with mortality in patients on long-term peritoneal dialysis.
    Goldfarb-Rumyantzev AS; Habib AN; Baird BC; Barenbaum LL; Cheung AK
    Am J Kidney Dis; 2007 Nov; 50(5):791-802. PubMed ID: 17954292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of diabetic retinopathy: could lipid-lowering be a worthwhile treatment modality?
    Dodson PM
    Eye (Lond); 2009 May; 23(5):997-1003. PubMed ID: 19169236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.